119 related articles for article (PubMed ID: 29335720)
1. Review: Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas.
Genere N; Montori VM
Ann Intern Med; 2018 Jan; 168(2):JC8. PubMed ID: 29335720
[No Abstract] [Full Text] [Related]
2. [Hardly any hypoglycemias, constant weight--and still cost effective].
MMW Fortschr Med; 2005 Nov; 147(47):72-3. PubMed ID: 16370200
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes.
Kwon CS; Seoane-Vazquez E; Rodriguez-Monguio R
BMC Health Serv Res; 2018 Feb; 18(1):78. PubMed ID: 29391064
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of thiazolidinediones in uncontrolled type 2 diabetic patients receiving sulfonylureas and metformin in Thailand.
Chirakup S; Chaiyakunapruk N; Chaikledkeaw U; Pongcharoensuk P; Ongphiphadhanakul B; Roze S; Valentine WJ; Palmer AJ
Value Health; 2008 Mar; 11 Suppl 1():S43-51. PubMed ID: 18387067
[TBL] [Abstract][Full Text] [Related]
5. [Not Available].
Viardot A
Ther Umsch; 2017; 74(8):423-431. PubMed ID: 29461148
[No Abstract] [Full Text] [Related]
6. Comparative cost-effectiveness of metformin-based dual therapies associated with risk of cardiovascular diseases among Chinese patients with type 2 diabetes: Evidence from a population-based national cohort in Taiwan.
Ou HT; Chen YT; Liu YM; Wu JS
Diabetes Res Clin Pract; 2016 Jun; 116():14-25. PubMed ID: 27321311
[TBL] [Abstract][Full Text] [Related]
7. Oral combination therapy in primary care.
Kalra S; Gupta Y
J Pak Med Assoc; 2015 May; 65(5):574-5. PubMed ID: 26028398
[TBL] [Abstract][Full Text] [Related]
8. [How I treat...The choice between a sulphonylulrea and a gliptin to manage hyperglycaemia in type 2 diabetes].
Scheen AJ
Rev Med Liege; 2014 Sep; 69(9):476-84. PubMed ID: 25796755
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective.
Thompson PL; Davis TME
Clin Ther; 2017 May; 39(5):1012-1025. PubMed ID: 27863704
[TBL] [Abstract][Full Text] [Related]
10. [Sulfonylureas].
Kobayashi K; Shimano H
Nihon Rinsho; 2012 May; 70 Suppl 3():602-7. PubMed ID: 22768585
[No Abstract] [Full Text] [Related]
11. The second-generation sulfonylureas: change or progress?
Kreisberg RA
Ann Intern Med; 1985 Jan; 102(1):125-6. PubMed ID: 3966729
[No Abstract] [Full Text] [Related]
12. Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes.
Barry HC
Am Fam Physician; 2016 Sep; 94(5):386. PubMed ID: 27583428
[No Abstract] [Full Text] [Related]
13. Cost-effectiveness of saxagliptin vs glimepiride as a second-line therapy added to metformin in Type 2 diabetes in China.
Gu S; Deng J; Shi L; Mu Y; Dong H
J Med Econ; 2015; 18(10):808-20. PubMed ID: 25950193
[TBL] [Abstract][Full Text] [Related]
14. Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): good for sulfonylureas?
Al-Ozairi E; Sibal L; Home P
Diabetes Care; 2007 Jun; 30(6):1677-80. PubMed ID: 17351288
[No Abstract] [Full Text] [Related]
15. Failure of sulfonylureas in type 2 diabetes.
Yildiz BO; Gürlek A
Horm Metab Res; 1999 Apr; 31(4):293-4. PubMed ID: 10333089
[No Abstract] [Full Text] [Related]
16. [Risk and benefit of sulfonylureas--their role in view of new treatment options for type 2 diabetes].
Rustenbeck I
Med Monatsschr Pharm; 2016 Feb; 39(2):65-72; quiz 73-4. PubMed ID: 26983335
[TBL] [Abstract][Full Text] [Related]
17. Insulin responses to sulfonylureas.
Cerasi E
Diabetes Res Clin Pract; 2002 Apr; 56(1):69-70; author reply 71. PubMed ID: 11879723
[No Abstract] [Full Text] [Related]
18. [40 years of using sulfonylurea derivatives for treatment of diabetes].
Sieradzki J
Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529
[TBL] [Abstract][Full Text] [Related]
19. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
Charbonnel B
Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness of add-on treatments to metformin in a Swedish setting: liraglutide vs sulphonylurea or sitagplitin.
Steen Carlsson K; Persson U
J Med Econ; 2014 Sep; 17(9):658-69. PubMed ID: 24950434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
